rs72650663

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_022168.4(IFIH1):​c.2105C>T​(p.Thr702Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00331 in 1,612,420 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T702T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0025 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0034 ( 18 hom. )

Consequence

IFIH1
NM_022168.4 missense

Scores

18

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.177

Publications

14 publications found
Variant links:
Genes affected
IFIH1 (HGNC:18873): (interferon induced with helicase C domain 1) IFIH1 encodes MDA5 which is an intracellular sensor of viral RNA that triggers the innate immune response. Sensing RNA length and secondary structure, MDA5 binds dsRNA oligonucleotides with a modified DExD/H-box helicase core and a C-terminal domain, thus leading to a proinflammatory response that includes interferons. It has been shown that Coronaviruses (CoVs) as well as various other virus families, are capable of evading the MDA5-dependent interferon response, thus impeding the activation of the innate immune response to infection. MDA5 has also been shown to play an important role in enhancing natural killer cell function in malaria infection. In addition to its protective role in antiviral responses, MDA5 has been implicated in autoimmune and autoinflammatory diseases such as type 1 diabetes, systemic lupus erythematosus, and Aicardi-Goutieres syndrome[provided by RefSeq, Jul 2020]
IFIH1 Gene-Disease associations (from GenCC):
  • Aicardi-Goutieres syndrome 7
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Illumina, Labcorp Genetics (formerly Invitae), G2P
  • Singleton-Merten syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Aicardi-Goutieres syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Singleton-Merten dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • immunodeficiency 95
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0051235557).
BP6
Variant 2-162276886-G-A is Benign according to our data. Variant chr2-162276886-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 541787.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00248 (377/152120) while in subpopulation NFE AF = 0.00431 (293/67988). AF 95% confidence interval is 0.0039. There are 2 homozygotes in GnomAd4. There are 162 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022168.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IFIH1
NM_022168.4
MANE Select
c.2105C>Tp.Thr702Ile
missense
Exon 11 of 16NP_071451.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IFIH1
ENST00000649979.2
MANE Select
c.2105C>Tp.Thr702Ile
missense
Exon 11 of 16ENSP00000497271.1
IFIH1
ENST00000648433.1
c.1988C>Tp.Thr663Ile
missense
Exon 10 of 15ENSP00000496816.1
IFIH1
ENST00000679938.1
c.1793C>Tp.Thr598Ile
missense
Exon 10 of 15ENSP00000505518.1

Frequencies

GnomAD3 genomes
AF:
0.00248
AC:
377
AN:
152002
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000628
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.00404
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.000661
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00431
Gnomad OTH
AF:
0.00336
GnomAD2 exomes
AF:
0.00235
AC:
587
AN:
249830
AF XY:
0.00248
show subpopulations
Gnomad AFR exome
AF:
0.000432
Gnomad AMR exome
AF:
0.00111
Gnomad ASJ exome
AF:
0.00408
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000601
Gnomad NFE exome
AF:
0.00397
Gnomad OTH exome
AF:
0.00246
GnomAD4 exome
AF:
0.00340
AC:
4964
AN:
1460300
Hom.:
18
Cov.:
31
AF XY:
0.00343
AC XY:
2492
AN XY:
726402
show subpopulations
African (AFR)
AF:
0.000599
AC:
20
AN:
33402
American (AMR)
AF:
0.00128
AC:
57
AN:
44506
Ashkenazi Jewish (ASJ)
AF:
0.00398
AC:
104
AN:
26102
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39628
South Asian (SAS)
AF:
0.000524
AC:
45
AN:
85802
European-Finnish (FIN)
AF:
0.000955
AC:
51
AN:
53416
Middle Eastern (MID)
AF:
0.00399
AC:
23
AN:
5760
European-Non Finnish (NFE)
AF:
0.00399
AC:
4432
AN:
1111342
Other (OTH)
AF:
0.00384
AC:
232
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
226
453
679
906
1132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00248
AC:
377
AN:
152120
Hom.:
2
Cov.:
32
AF XY:
0.00218
AC XY:
162
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.000626
AC:
26
AN:
41502
American (AMR)
AF:
0.00157
AC:
24
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00404
AC:
14
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4828
European-Finnish (FIN)
AF:
0.000661
AC:
7
AN:
10592
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00431
AC:
293
AN:
67988
Other (OTH)
AF:
0.00332
AC:
7
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00336
Hom.:
1
Bravo
AF:
0.00243
TwinsUK
AF:
0.00431
AC:
16
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00314
AC:
27
ExAC
AF:
0.00219
AC:
266
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00536
EpiControl
AF:
0.00523

ClinVar

Significance: Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

IFIH1: BP4, BS2

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Aicardi-Goutieres syndrome 7 Benign:1
Jun 30, 2020
Genetics and Molecular Pathology, SA Pathology
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aicardi-Goutieres syndrome 7;C4225427:Singleton-Merten syndrome 1 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

IFIH1-related disorder Benign:1
Feb 25, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.3
DANN
Benign
0.89
DEOGEN2
Benign
0.11
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.073
N
LIST_S2
Benign
0.64
T
M_CAP
Benign
0.0031
T
MetaRNN
Benign
0.0051
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.0
L
PhyloP100
-0.18
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.030
Sift
Benign
0.23
T
Sift4G
Benign
0.22
T
Polyphen
0.0
B
Vest4
0.15
MVP
0.15
MPC
0.025
ClinPred
0.0012
T
GERP RS
-5.6
Varity_R
0.076
gMVP
0.14
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72650663; hg19: chr2-163133396; API